The stock of Zomedica Corp (ZOM) has seen a 4.77% increase in the past week, with a -6.58% drop in the past month, and a 1.72% flourish in the past quarter. The volatility ratio for the week is 3.88%, and the volatility levels for the past 30 days are at 4.36% for ZOM. The simple moving average for the past 20 days is 0.56% for ZOM’s stock, with a -17.54% simple moving average for the past 200 days.
Is It Worth Investing in Zomedica Corp (AMEX: ZOM) Right Now?
ZOM has 36-month beta value of 1.00. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for ZOM is 964.36M, and currently, short sellers hold a 6.30% ratio of that float. The average trading volume of ZOM on April 29, 2024 was 4.74M shares.
ZOM) stock’s latest price update
Zomedica Corp (AMEX: ZOM) has seen a rise in its stock price by 2.48 in relation to its previous close of 0.13. However, the company has experienced a 4.77% gain in its stock price over the last five trading sessions. Accesswire reported 2024-04-09 that ANN ARBOR, MI / ACCESSWIRE / April 9, 2024 / Zomedica Corp. (NYSE American:ZOM) (“Zomedica” or the “Company”), a veterinary health company offering point-of-care diagnostic and therapeutic device products for equine and companion animals, today announced that its Chief Executive Officer, Larry Heaton, will present at the Noble Capital Markets’ Emerging Growth Virtual Healthcare Equity Conference on Wednesday, April 17, 9:30 a.m. – 10:00 a.m.
Analysts’ Opinion of ZOM
Many brokerage firms have already submitted their reports for ZOM stocks, with Dawson James repeating the rating for ZOM by listing it as a “Buy.” The predicted price for ZOM in the upcoming period, according to Dawson James is $6 based on the research report published on January 06, 2023 of the previous year 2023.
ZOM Trading at 1.03% from the 50-Day Moving Average
After a stumble in the market that brought ZOM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -44.37% of loss for the given period.
Volatility was left at 4.36%, however, over the last 30 days, the volatility rate increased by 3.88%, as shares sank -3.00% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -2.30% lower at present.
During the last 5 trading sessions, ZOM rose by +4.38%, which changed the moving average for the period of 200-days by -39.24% in comparison to the 20-day moving average, which settled at $0.1353. In addition, Zomedica Corp saw -31.92% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ZOM starting from POWERS JOHNNY D, who purchase 100,000 shares at the price of $0.17 back on Dec 15 ’23. After this action, POWERS JOHNNY D now owns 1,950 shares of Zomedica Corp, valued at $16,500 using the latest closing price.
POWERS JOHNNY D, the Director of Zomedica Corp, purchase 100,000 shares at $0.17 during a trade that took place back on Nov 17 ’23, which means that POWERS JOHNNY D is holding 1,850,000 shares at $16,600 based on the most recent closing price.
Stock Fundamentals for ZOM
Current profitability levels for the company are sitting at:
- -1.25 for the present operating margin
- 0.61 for the gross margin
The net margin for Zomedica Corp stands at -1.37. The total capital return value is set at -0.13. Equity return is now at value -13.61, with -12.96 for asset returns.
Based on Zomedica Corp (ZOM), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at -5.78. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is -658.15.
Currently, EBITDA for the company is -25.29 million with net debt to EBITDA at 0.43. When we switch over and look at the enterprise to sales, we see a ratio of 4.95. The receivables turnover for the company is 11.46for trailing twelve months and the total asset turnover is 0.1. The liquidity ratio also appears to be rather interesting for investors as it stands at 11.06.
Conclusion
To put it simply, Zomedica Corp (ZOM) has had a mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
